Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 100,229 | 104,824 | 116,492 | 57,567 | 54,440 |
| Cost of Goods | 7,418 | 4,942 | 4,915 | 3,613 | 4,243 |
| Gross Profit | 92,811 | 99,882 | 111,577 | 53,954 | 50,197 |
| Operating Expenses | 145,124 | 134,535 | 121,853 | 106,505 | 110,180 |
| Operating Income | -51,895 | -33,711 | -9,361 | -51,938 | -59,740 |
| Interest Expense | 6,118 | 4,813 | 4,200 | 3,493 | 3,479 |
| Other Income | 1,591 | 1,018 | 486 | 136 | 70 |
| Pre-tax Income | -56,422 | -37,506 | -13,075 | -55,295 | -63,149 |
| Income Tax | 1,205 | 8,113 | 8,164 | 3,990 | 296 |
| Net Income Continuous | -57,627 | -45,619 | -21,239 | -59,285 | -63,445 |
| Net Income | $-57,627 | $-45,619 | $-21,239 | $-59,285 | $-63,445 |
| EPS Basic Total Ops | -0.59 | -0.47 | -0.22 | -0.64 | -0.68 |
| EPS Basic Continuous Ops | -0.60 | -0.47 | -0.22 | -0.63 | -0.68 |
| EPS Diluted Total Ops | -0.59 | -0.47 | -0.22 | -0.64 | -0.68 |
| EPS Diluted Continuous Ops | -0.60 | -0.47 | -0.22 | -0.63 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.47 | -0.22 | -0.63 | -0.68 |
| EBITDA(a) | $-51,013 | $-32,901 | $-8,566 | $-48,765 | $-58,964 |